Letter by Le Ruz and Manigold Regarding Article, "Compared Outcomes ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER MI Trial".
Robin Le RuzThibaut ManigoldPublished in: Circulation. Cardiovascular interventions (2022)
Keyphrases
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- st elevation myocardial infarction
- acute myocardial infarction
- acute coronary syndrome
- coronary artery disease
- coronary artery bypass grafting
- antiplatelet therapy
- clinical trial
- coronary artery bypass
- atrial fibrillation
- study protocol
- phase ii
- heart failure
- newly diagnosed
- phase iii
- randomized controlled trial
- metabolic syndrome
- open label
- insulin resistance
- skeletal muscle
- left ventricular